A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that leverages its financial strength to beat its competitors and two that may struggle to keep up.
Two Stocks to Sell:
Allient (ALNT)
Trailing 12-Month Free Cash Flow Margin: 4.8%
Founded in 1962, Allient (NASDAQ: ALNT) develops and manufactures precision and specialty-controlled motion components and systems.
Why Are We Cautious About ALNT?
- Sales stagnated over the last two years and signal the need for new growth strategies
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
- Underwhelming 7.8% return on capital reflects management’s difficulties in finding profitable growth opportunities
Allient’s stock price of $114.36 implies a valuation ratio of 37.8x forward P/E. Check out our free in-depth research report to learn more about why ALNT doesn’t pass our bar.
Bristol-Myers Squibb (BMY)
Trailing 12-Month Free Cash Flow Margin: 23.3%
With roots dating back to 1887 and a transformative merger in 1989 that gave the company its current name, Bristol-Myers Squibb (NYSE: BMY) discovers, develops, and markets prescription medications for serious diseases including cancer, blood disorders, immunological conditions, and cardiovascular diseases.
Why Do We Think Twice About BMY?
- Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 2.1% over the last five years was below our standards for the healthcare sector
- Day-to-day expenses have swelled relative to revenue over the last five years as its adjusted operating margin fell by 8.2 percentage points
- Performance over the past five years shows its incremental sales were less profitable as its earnings per share were flat
At $63.96 per share, Bristol-Myers Squibb trades at 9.8x forward P/E. If you’re considering BMY for your portfolio, see our FREE research report to learn more.
One Stock to Watch:
Copart (CPRT)
Trailing 12-Month Free Cash Flow Margin: 27.2%
Starting as a single salvage yard in California in 1982, Copart (NASDAQ: CPRT) operates an online auction platform that connects sellers of damaged and salvage vehicles with buyers ranging from dismantlers and rebuilders to used car dealers and exporters.
Why Could CPRT Be a Winner?
- Impressive 11.6% annual revenue growth over the last five years indicates it’s winning market share this cycle
- Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its recently improved profitability means it has even more resources to invest or distribute
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures
Copart is trading at $27.31 per share, or 17x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
